|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0012133,
umls-concept:C0030705,
umls-concept:C0034656,
umls-concept:C0043474,
umls-concept:C0205210,
umls-concept:C0220912,
umls-concept:C0220913,
umls-concept:C0868945,
umls-concept:C1257890,
umls-concept:C1707455,
umls-concept:C2603343
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1994-3-4
|
|
pubmed:abstractText |
To determine the benefits of switching to didanosine compared with continuing zidovudine among patients infected with human immunodeficiency virus (HIV) who have previously used zidovudine and have signs of clinical deterioration.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0003-4819
|
|
pubmed:author |
pubmed-author:BernsteinB MBM,
pubmed-author:BerryAA,
pubmed-author:BrandJJ,
pubmed-author:BrownM JMJ,
pubmed-author:CraneLL,
pubmed-author:CrossAA,
pubmed-author:DunkleL MLM,
pubmed-author:FrankII,
pubmed-author:GreenS LSL,
pubmed-author:GugliottiRR,
pubmed-author:IngrahamPP,
pubmed-author:MacArthurR DRD,
pubmed-author:MoreyG EGE,
pubmed-author:PachuckiC TCT,
pubmed-author:PattersonT FTF,
pubmed-author:PaviaA TAT,
pubmed-author:PetersonDD,
pubmed-author:PetersonE AEA,
pubmed-author:PollardRR,
pubmed-author:Ramirez-RondaC HCH,
pubmed-author:RemickS CSC,
pubmed-author:RiouGG,
pubmed-author:SchindzielorzA HAH,
pubmed-author:SmaldoneLL,
pubmed-author:SpruanceS LSL,
pubmed-author:SweetD EDE,
pubmed-author:ThompsonMM
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
120
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
360-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:7905722-AIDS-Related Complex,
pubmed-meshheading:7905722-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:7905722-Adult,
pubmed-meshheading:7905722-Aged,
pubmed-meshheading:7905722-CD4-Positive T-Lymphocytes,
pubmed-meshheading:7905722-Didanosine,
pubmed-meshheading:7905722-Double-Blind Method,
pubmed-meshheading:7905722-Female,
pubmed-meshheading:7905722-Humans,
pubmed-meshheading:7905722-Leukocyte Count,
pubmed-meshheading:7905722-Male,
pubmed-meshheading:7905722-Middle Aged,
pubmed-meshheading:7905722-Zidovudine
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group.
|
|
pubmed:affiliation |
Holy Cross Hospital, Salt Lake City, Utah.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
